0001179110-20-003228.txt : 20200306
0001179110-20-003228.hdr.sgml : 20200306
20200306161049
ACCESSION NUMBER: 0001179110-20-003228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vandervoort Adam C
CENTRAL INDEX KEY: 0001375088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20694876
MAIL ADDRESS:
STREET 1: 485 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-05
0
0001477449
Teladoc Health, Inc.
TDOC
0001375088
Vandervoort Adam C
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Legal Officer, Secretary
Common Stock
2020-03-05
4
M
0
4491
A
8337
D
Common Stock
2020-03-05
4
F
0
2160
132.73
D
6177
D
Common Stock
2020-03-05
4
M
0
3454
A
9631
D
Common Stock
2020-03-05
4
F
0
1548
132.73
D
8083
D
Performance Stock Units
2020-03-05
4
M
0
4491
0.00
D
Common Stock
4491
8981
D
Restricted Stock Units
2020-03-05
4
M
0
3454
0.00
D
Common Stock
3454
6909
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
On February 26, 2020, the reporting person earned 13,472 performance stock units, vesting in three annual installments beginning on March 4, 2020.
On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Adam C. Vandervoort
2020-03-06